AINDEX
Markets

Blackstone Inc. (BX)

BXNYSEInvestment Managers

$125.03

+5.53 (+4.63%) today

Closed, Nov 9, 4:03 PM ET

+4.63% 1D
Market cap
$93.14bn
P/E
21.0
EPS, last 4 quarters
$5.95
Dividend yield
–
Day range
–
52-week range
$101.73 to $165.14
Average volume
2.94m
Previous close
$119.50

Analysts

16 covering

Hold9 buy, 7 hold, 0 sell

Targets a year out average $137.50, +10.0% from here

$118.00now $125.03$169.00

Earnings

next estimate $1.71

Next report

Dec 2025

+15.1%

Mar 2026

+0.7%

Jun 2026

+14.3%

Sep 2026

+4.8%

estimate reported, and the surprise

Financials

QuarterDec 2025Mar 2026Jun 2026Sep 2026
Revenue$4.23bn$3.48bn$4.90bn$2.93bn
Gross profit$4.23bn$3.48bn$4.90bn$2.93bn
Operating income$2.24bn$1.36bn$2.67bn$1.44bn
Net income$1.02bn$649.73m$1.23bn$662.37m

Last four quarters: revenue $15.54bn, margin 22.9%, free cash flow $5.83bn

News

8 latest

The company

Blackstone Life Sciences is an industry-leading private investment platform with capabilities to invest across the life cycle of companies and products within the key life science sectors. By combining scale investments and hands-on operational leadership, Blackstone Life Sciences helps bring to market promising new medicines and medical technologies that improve patients' lives and currently has $18 billion in assets under management.

Sector
Finance
Industry
Investment Managers
Exchange
NYSE
Region
North America

Often looked at with it

Figures from Yahoo, Nasdaq (Zacks consensus) and Lighter. Stocks can be minutes behind. Nothing here is advice.

Blackstone Inc. (BX) price, chart and news · AINDEX